Intra-Articular Dexmedetomidine: A Treatment for Chronic Knee Pain
RecruitingNot applicableNCT06641206
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic knee osteoarthritis (KOA) is a painful condition with limited treatment options. Non-pharmacological approaches often fall short, leading to decreased quality of life. Ozone therapy, a simple and affordable treatment, has shown promise for pain relief. Dexmedetomidine (DEX), a sedative and analgesic, has been used successfully as an adjuvant to anesthesia and local anesthetics. Given its potential for pain management, exploring DEX as a treatment for KOA could offer a new and promising approach.
Study details
- Official title
- Intra-articular Dexmedetomidine for Treatment of Chronic Knee Pain: A Prospective Case-Control Clinical Trial
- Conditions
- Interventions
- Drug: Triamcinolone Acetonide
- Drug: Bupivacaine Hydrochloride
- Drug: Dexmedetomidine
- Sponsor
- Tanta University
- Start date
- 2024-09-17
- Primary completion
- 2025-01
- Sex
- All
- Age range
- from 40 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients were not assigned for surgical intervention; * Patients were free of exclusion criteria Exclusion Criteria: * Patients were assigned for surgical intervention; * Patients who had uncontrolled hypertension and/or diabetes mellitus; * Patients who had uncompensated cardiac, renal, or hepatic diseases; * Patients with coagulopathy, spinal deformity, allergy, or contraindication for the used drugs; * Patients who refused to sign the informed consent were excluded from the study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06641206